A similar mechanism may downregulate PI3K, AKT, and ETV7 levels and thereby reduce breast cancer cells’ invasiveness via the proposed VD3-GNP (24 h) treatment (Figure 8). The gene discussed is AKT1; the disease is breast carcinoma.